PubRank

James N George

Author PubWeight™ 125.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2008 7.06
2 Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010 5.23
3 In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs. Mayo Clin Proc 2015 4.70
4 AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP. N Engl J Med 2006 4.07
5 ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003 3.88
6 Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008 3.74
7 Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2009 3.18
8 Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications. Blood 2004 2.42
9 Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004 1.94
10 Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: report of five patients with a systematic review of published reports. Haematologica 2007 1.87
11 The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports. Am J Hematol 2010 1.83
12 Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood 2010 1.76
13 Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review. Ann Intern Med 2004 1.69
14 Corticosteroid side-effects and risk for bleeding in immune thrombocytopenic purpura: patient and hematologist perspectives. Eur J Haematol 2009 1.56
15 Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf 2009 1.52
16 Complete recovery from refractory immune thrombocytopenic purpura in three patients treated with etanercept. Am J Hematol 2003 1.50
17 Pregnancy outcomes following recovery from acquired thrombotic thrombocytopenic purpura. Blood 2014 1.47
18 Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases. Oncologist 2007 1.45
19 Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 2007 1.39
20 Management of immune thrombocytopenia--something old, something new. N Engl J Med 2010 1.39
21 Decreasing frequency of plasma exchange complications in patients treated for thrombotic thrombocytopenic purpura-hemolytic uremic syndrome, 1996 to 2011. Transfusion 2012 1.27
22 Syndromes of thrombotic microangiopathy. N Engl J Med 2014 1.25
23 Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transfus Med Rev 2013 1.20
24 Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review. Transfusion 2007 1.19
25 Recurrent acute thrombocytopenia in the hospitalized patient: sepsis, DIC, HIT, or antibiotic-induced thrombocytopenia. Am J Hematol 2010 1.18
26 Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features. Pediatr Blood Cancer 2013 1.16
27 Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2006 1.14
28 Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 2013 1.13
29 Systemic infections mimicking thrombotic thrombocytopenic purpura. Am J Hematol 2011 1.10
30 Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura. Transfusion 2009 1.09
31 Thrombocytopenia as an adverse effect of complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages. Eur J Haematol 2010 1.08
32 Pregnancy-induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw-Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients. Br J Haematol 2008 1.03
33 Cyclosporin and plasma exchange in thrombotic thrombocytopenic purpura: long-term follow-up with serial analysis of ADAMTS13 activity. Br J Haematol 2007 1.00
34 Evidence for a role of anti-ADAMTS13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thrombocytopenic purpura. Haematologica 2011 0.99
35 Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfusion 2004 0.98
36 A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: its development and validation. Health Qual Life Outcomes 2007 0.98
37 Self-reported health-related quality of life in adults with chronic immune thrombocytopenic purpura. Am J Hematol 2008 0.97
38 Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006 0.95
39 Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective. Health Qual Life Outcomes 2008 0.95
40 An evaluation of cyclosporin and corticosteroids individually as adjuncts to plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Br J Haematol 2006 0.94
41 Fatigue in adult patients with primary immune thrombocytopenia. Eur J Haematol 2011 0.93
42 Different disparities of gender and race among the thrombotic thrombocytopenic purpura and hemolytic-uremic syndromes. Am J Hematol 2010 0.92
43 Thrombotic thrombocytopenic purpura: 2008 update. Cleve Clin J Med 2008 0.92
44 Cognitive deficits after recovery from thrombotic thrombocytopenic purpura. Transfusion 2009 0.92
45 Should all adult patients with diarrhoea-associated HUS receive plasma exchange? Lancet 2012 0.91
46 Frequency and significance of HIV infection among patients diagnosed with thrombotic thrombocytopenic purpura. Clin Infect Dis 2009 0.91
47 A disease-specific measure of health-related quality of life in adults with chronic immune thrombocytopenic purpura: psychometric testing in an open-label clinical trial. Clin Ther 2007 0.90
48 Complications of plasma exchange in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a study of 78 additional patients. Transfusion 2003 0.90
49 Blood group O and black race are independent risk factors for thrombotic thrombocytopenic purpura associated with severe ADAMTS13 deficiency. Transfusion 2011 0.90
50 Drug-induced thrombocytopenia in children. Pediatr Blood Cancer 2013 0.90
51 Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study. Transplantation 2008 0.89
52 Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol 2012 0.88
53 Referral of patients with thrombocytopenia from primary care clinicians to hematologists. Blood 2009 0.88
54 Drug-induced thrombocytopenia: an updated systematic review, 2006. Drug Saf 2007 0.88
55 First symptoms in patients with thrombotic thrombocytopenic purpura: what are they and when do they occur? Transfusion 2013 0.86
56 Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease. Haematologica 2008 0.86
57 Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008. Transfusion 2009 0.86
58 Use of erythropoietin in cancer patients: assessment of oncologists' practice patterns in the United States and other countries. Am J Med 2004 0.85
59 The effect of an intense mentoring program on junior investigators' preparation for a patient-oriented clinical research career. Acad Med 2015 0.85
60 A blinded study of bone marrow examinations in patients with primary immune thrombocytopenia. Eur J Haematol 2012 0.85
61 Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 2007 0.84
62 Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura. Transfusion 2008 0.84
63 Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003 0.84
64 Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison. Br J Haematol 2008 0.84
65 Thrombotic thrombocytopenic purpura: advances in pathophysiology, diagnosis, and treatment--introduction. Semin Hematol 2004 0.84
66 Salmonella sepsis caused by a platelet transfusion from a donor with a pet snake. N Engl J Med 2002 0.83
67 Plasma exchange complications in patients treated for thrombotic thrombocytopenia purpura-hemolytic uremic syndrome: 2011 to 2014. Transfusion 2014 0.82
68 Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. Am J Hematol 2015 0.81
69 Determining a definite diagnosis of primary immune thrombocytopenia by medical record review. Am J Hematol 2012 0.81
70 The child with immune thrombocytopenic purpura: is pharmacotherapy or watchful waiting the best initial management? A panel discussion from the 2002 meeting of the American Society of Pediatric Hematology/Oncology. J Pediatr Hematol Oncol 2004 0.81
71 Support groups for patients who have recovered from thrombotic thrombocytopenic purpura. J Clin Apher 2008 0.81
72 The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a community service. J Okla State Med Assoc 2007 0.81
73 Treatment of drug-induced thrombocytopenia. Expert Opin Drug Saf 2002 0.81
74 Complete remission of refractory immune thrombocytopenia (ITP) with a short course of Romiplostim. Eur J Haematol 2013 0.81
75 Definition, diagnosis and treatment of immune thrombocytopenic purpura. Haematologica 2009 0.81
76 A support group for patients who have recovered from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): The six-year experience of the Oklahoma TTP-HUS Study Group. J Clin Apher 2003 0.81
77 Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006. Transfusion 2007 0.81
78 Is immune thrombocytopenic purpura less common among black Americans? Blood 2005 0.80
79 Recent advances in the treatment of chronic refractory immune thrombocytopenic purpura. Int J Hematol 2005 0.80
80 Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura. Am J Hematol 2008 0.80
81 Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura. Br J Haematol 2010 0.80
82 Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients. Am J Hematol 2009 0.80
83 Quinine allergy causing acute severe systemic illness: report of 4 patients manifesting multiple hematologic, renal, and hepatic abnormalities. Proc (Bayl Univ Med Cent) 2003 0.80
84 Demographic and ADAMTS13 biomarker data as predictors of early recurrences of idiopathic thrombotic thrombocytopenic purpura. Eur J Haematol 2009 0.79
85 Validation of claims-based diagnostic codes for idiopathic thrombotic thrombocytopenic purpura in a commercially-insured population. Thromb Haemost 2010 0.79
86 Bilateral nephrectomy for treatment resistant systemic lupus erythematosis and thrombotic thrombocytopenic purpura: a case report. Am J Hematol 2007 0.79
87 Novel thrombopoietic agents: a new era for management of patients with thrombocytopenia. Haematologica 2008 0.79
88 Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005. J Okla State Med Assoc 2007 0.78
89 Severe vitamin B-12 deficiency in a child mimicking thrombotic thrombocytopenic purpura. Pediatr Blood Cancer 2009 0.78
90 Drug-induced thrombocytopenia: an updated systematic review, 2010. Drug Saf 2011 0.77
91 Drug-induced thrombocytopenia: an updated systematic review, 2012. Drug Saf 2012 0.77
92 Health care utilization of patients diagnosed with idiopathic thrombotic thrombocytopenic purpura in a commercially insured population in the United States. Transfusion 2012 0.76
93 Management of primary immune thrombocytopenia, 2012: a survey of oklahoma hematologists-oncologists. Am J Med Sci 2014 0.76
94 How can we provide the best care for our patients with immune thrombocytopenic pupura? Mayo Clin Proc 2004 0.76
95 Immune thrombocytopenic purpura--let the treatment fit the patient. N Engl J Med 2003 0.76
96 Idiopathic thrombocytopenic purpura and myelodysplastic syndrome: distinct entities or overlapping syndromes? Leuk Res 2002 0.76
97 Autoimmune hemolytic anemia and thrombocytopenia attributed to an intrauterine contraceptive device. Transfusion 2014 0.75
98 Addendum to corticosteroid side effects and risk for bleeding in immune thrombocytopenic purpura: patient perspectives. Eur J Haematol 2009 0.75
99 Irinotecan-induced immune thrombocytopenia. Am J Med Sci 2014 0.75
100 A seasonal association of incident cases of thrombotic thrombocytopenic purpura was not observed in the Oklahoma TTP-HUS Registry. Transfusion 2012 0.75
101 Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura. Am J Hematol 2014 0.75
102 Thrombotic thrombocytopenic purpura: from the bench to the bedside, but not yet to the community. Ann Intern Med 2003 0.75
103 ADAMTS13: what it does, how it works, and why it's important. Transfusion 2009 0.75
104 Pulmonary involvement in patients with thrombotic thrombocytopenic purpura. Eur J Haematol 2013 0.75
105 Letter to authors and readers regarding the new NIH policy on public access. Blood 2005 0.75